Dividend
-
-
-
-
-
-
-
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis
-
445,307 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

